文献速递疝与腹壁外科

腹壁疝逐年复发率及危险因素

Year-Over-Year Ventral Hernia Recurrence Rates and Risk Factors.
PubMed 文献 · JAMA Surg · 2024-01-01

该回顾性、基于人群的研究利用腹壁核心健康质量协作注册数据库,评估2012年1月至2022年8月间既往腹壁疝修补患者的逐年复发率及危险因素。共分析网状片组29834例和无网状片组5599例,结果显示网状片组5年复发率为44.9%,无网状片组为73.7%,且多种因素与复发风险升高或降低相关。

要点

  • 网状片组5年复发率44.9%,无网状片组5年复发率73.7%。
  • 疝类型是与复发相关的最重要变量。
  • 较高的体重指数、免疫抑制剂、切口疝和造口旁疝、机器人入路、较大的疝宽度、使用生物或可吸收合成网状片以及手术部位感染和再手术与复发风险升高相关。

核心结论

  • 本研究显示腹壁疝修补术后5年复发率在网状片组和无网状片组分别大于40%和70%,腹壁疝复发率随时间增加,强调对该人群进行密切长期随访的重要性。

研究设计与样本

  • 本回顾性、基于人群的研究使用腹壁核心健康质量协作注册数据库,评估2012年1月至2022年8月间既往腹壁疝修补患者的逐年复发率,纳入至少1次 prior 腹壁疝修补的患者,并根据是否使用网状片分为2组,共43960例符合条件,排除并发腹股沟疝为主要诊断、非标准疝手术类别、美国麻醉医师协会分级未指定或无随访的患者后,网状片组29834例和无网状片组5599例纳入分析。

主要发现

  • 网状片组29834例平均(标准差)年龄57.17(13.36)岁,女性14331例(48.0%);无网状片组5599例平均(标准差)年龄51.9(15.31)岁,女性2458例(43.9%)。
  • Kaplan-Meier分析显示,网状片组与无网状片组相比,6个月复发率分别为2.8%(201例累积事件,13872例 at risk) vs 4.0%(104例累积事件,1707例 at risk);1年分别为8.0%(411例累积事件,4732例 at risk) vs 32.6%(184例累积事件,427例 at risk);2年分别为19.7%(640例累积事件,1518例 at risk) vs 52.4%(243例累积事件,146例 at risk);3年分别为29.3%(731例累积事件,670例 at risk) vs 61.4%(258例累积事件,73例 at risk);4年分别为38.5%(777例累积事件,337例 at risk) vs 71.2%(267例累积事件,29例 at risk);5年分别为44.9%(798例累积事件,171例 at risk) vs 73.7%(269例累积事件,19例 at risk)。
  • 较高的体重指数、免疫抑制剂、切口疝和造口旁疝、机器人入路、较大的疝宽度、使用生物或可吸收合成网状片以及手术部位感染和再手术等并发症与疝复发 odds 升高相关;较大的网状片宽度、肌筋膜松解和筋膜关闭与复发 odds 降低相关;疝类型是与复发相关的最重要变量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Recurrence is one of the most challenging adverse events after ventral hernia repair as it impacts quality of life, utilization of resources, and subsequent need for re-repair. Rates of recurrence range from 30% to 80% after ventral hernia repair. OBJECTIVE: To determine the contemporary ventral hernia recurrence rate over time in patients with previous hernia repair and to determine risk factors associated with recurrence. DESIGN, SETTING, AND PARTICIPANTS: This retrospective, population-based study used the Abdominal Core Health Quality Collaborative registry to evaluate year-over-year recurrence rates in patients with prior ventral hernia repair between January 2012 and August 2022. Patients who underwent at least 1 prior ventral hernia repair were included and categorized into 2 groups based on mesh or no-mesh use. There were 43 960 eligible patients; after exclusion criteria (patients with concurrent inguinal hernias as the primary diagnosis, nonstandard hernia procedure categories, American Society of Anesthesiologists class unassigned, or no follow-up), 29 834 patients were analyzed in the mesh group and 5599 in the no-mesh group. MAIN OUTCOMES AND MEASURES: Ventral hernia recurrence rates. Risk factors analyzed include age, body mass index, sex, race, insurance type, medical comorbidities, American Society of Anesthesiologists class, smoking, indication for surgery, concomitant procedure, hernia procedure type, myofascial release, fascial closure, fixation type, number of prior repairs, hernia width, hernia length, mesh width, mesh length, operative approach, prior mesh placement, prior mesh infection, mesh location, mesh type, postoperative surgical site occurrence, postoperative surgical site infection, postoperative seroma, use of drains, and reoperation. RESULTS: Among 29 834 patients with mesh, the mean (SD) age was 57.17 (13.36) years, and 14 331 participants (48.0%) were female. Among 5599 patients without mesh, the mean (SD) age was 51.9 (15.31) years, and 2458 participants (43.9%) were female. When comparing year-over-year hernia recurrence rates in patients with and without prior mesh repair, respectively, the Kaplan Meier analysis showed a recurrence rate of 201 cumulative events with 13 872 at risk (2.8%) vs 104 cumulative events with 1707 at risk (4.0%) at 6 months; 411 cumulative events with 4732 at risk (8.0%) vs 184 cumulative events with 427 at risk (32.6%) at 1 year; 640 cumulative events with 1518 at risk (19.7%) vs 243 cumulative events with 146 at risk (52.4%) at 2 years; 731 cumulative events with 670 at risk (29.3%) vs 258 cumulative events with 73 at risk (61.4%) at 3 years; 777 cumulative events with 337 at risk (38.5%) vs 267 cumulative events with 29 at risk (71.2%) at 4 years; and 798 cumulative events with 171 at risk (44.9%) vs 269 cumulative events with 19 at risk (73.7%) at 5 years. Higher body mass index; immunosuppressants; incisional and parastomal hernias; a robotic approach; greater hernia width; use of a biologic or resorbable synthetic mesh; and complications, such as surgical site infections and reoperation, were associated with higher odds of hernia recurrence. Conversely, greater mesh width, myofascial release, and fascial closure had lower odds of recurrence. Hernia type was the most important variable associated with recurrence. CONCLUSIONS AND RELEVANCE: In this study, the 5-year recurrence rate after ventral hernia repair was greater than 40% and 70% in patients with and without mesh, respectively. Rates of ventral hernia recurrence increased over time, underscoring the importance of close, long-term follow up in this population.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Bhardwaj P, Huayllani MT, Olson MA, et al. Year-Over-Year Ventral Hernia Recurrence Rates and Risk Factors. JAMA Surg. 2024. PMID: 38536183. doi:10.1001/jamasurg.2024.0233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。